2,4,5-Trichloropyrrolo[2,1-f][1,2,4]triazine, 98%, 250mg

Sodium 4-aminobenzoate, 95.0%, 100g

2-(Difluoromethyl)benzyl alcohol, 95%, 250mg

GC capillary column ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

(R)-BENZYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(DIMETHYLAMINO)-5-OXOPENTANOATE, 95.0%, 1g

3-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine hydrochloride, 95.0%, 1g

6-Chloro-2,3-dihydro-1H-indene-1-carboxylic acid, 95.0%, 1g

METHYL 4-((4-BROMOPHENETHYL)AMINO)-3-NITROBENZOATE, 90.0%, 250mg

4-(1H-Pyrazol-5-yl)benzoic acid, 95.0%, 25g

Cyclopropyl(3-methylpyridin-2-yl)methanamine dihydrochloride, 100mg

N-CYCLOHEXYL-N-METHYL-4-(1,2-DIHYDRO-2-OXO-6-QUINOLYLOXY)BUTYRAMIDE, 95%, 100mg

Sodium Diphenylamine-4-sulfonate>97.0%(HPLC)(N)1g

Protein L HRP Conjugate1vial